Cargando…
Effect of Anti-interleukin-17 Treatment on Haemoglobin A1c Levels
Autores principales: | SCHWARZ, Christopher Willy, LOFT, Nikolai Dyrberg, ZACHARIAE, Claus, SKOV, Lone |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society for Publication of Acta Dermato-Venereologica
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235003/ https://www.ncbi.nlm.nih.gov/pubmed/32852564 http://dx.doi.org/10.2340/00015555-3620 |
Ejemplares similares
-
Targeting of interleukin-17 in the treatment of psoriasis
por: Lønnberg, Ann Sophie, et al.
Publicado: (2014) -
Improvement of Psoriasis, Psoriatic Arthritis, and Alopecia Universalis during Treatment with Tofacitinib: A Case Report
por: Todberg, Tanja, et al.
Publicado: (2020) -
Efficacy of Apremilast in Patients with Prurigo Nodularis: A Proof-of-concept Study
por: TODBERG, Tanja, et al.
Publicado: (2020) -
Response to Interleukin-17A Inhibitors According to Prior Biologic Exposures: A Danish Nationwide Study
por: LOFT, Nikolai, et al.
Publicado: (2023) -
Blood Cell Biomarkers of Inflammation and Cytokine Levels as Predictors of Response to Biologics in Patients with Psoriasis
por: Andersen, Clara Sophie Bramsen, et al.
Publicado: (2023)